Health

The Economic Upside To Vaccinating

"Vaccination is one of the most cost-effective interventions in public health."

"Vaccination is one of the most cost-effective interventions in public health."

Sachiko Ozawa, an associate professor at the UNC Eshelman School of Pharmacy who studies the effects of vaccinations on global health, projects that by 2020, Gavi — a global vaccine alliance started in 2000 that offers children the opportunity to get vaccines in third-world countries — will have prevented 20 million child deaths. It will have also saved $350 billion.

“Vaccination is generally regarded to be one of the most cost-effective interventions in public health,” Ozawa said.

To date, Gavi has immunized 580 million children in 73 countries. The value of preserved productivity, quality of life and other broad economic and social benefits for all 73 study countries is estimated to reach $820 billion by 2020, the researchers calculated.

Read the complete Carolina Story from the UNC Eshelman School of Pharmacy…Opens in new window

The study, which was published in the Bulletin of the World Health Organization, was was performed with financial support from the Bill & Melinda Gates Foundation.

UNC Eshelman School of Pharmacy Funding Priorities

    Readers Also Viewed...

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers